Elite Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	26.62	11.32	7.11	7.83	8.54	3.19
Cash & Short-Term Investments	26.62	11.32	7.11	7.83	8.54	3.19
Cash Growth	178.57%	59.23%	-9.27%	-8.24%	167.33%	182.11%
Receivables	40.87	29.21	19.45	3.09	3.06	3.5
Inventory	18.16	16.24	12.93	9.55	6.74	5.01
Prepaid Expenses	0.14	0.98	0.52	1.03	0.53	0.49
Total Current Assets	85.79	57.74	40.01	21.51	18.86	12.19
Property, Plant & Equipment	13.4	14.1	14.61	10.44	6.98	6.86
Other Intangible Assets	0.29	0.29	0.29	0.29	0.47	0.47
Long-Term Deferred Tax Assets	11.8	18.37	22.16	2.17	2.17	-
Long-Term Deferred Charges	5.35	5.35	6.05	6.05	6.17	6.17
Other Long-Term Assets	0.61	0.55	0.53	0.43	0.5	0.5
Total Assets	117.25	96.39	83.65	40.9	35.15	26.19
Accounts Payable	3.42	2.96	2.71	2.45	1.43	0.93
Accrued Expenses	5.88	3.45	4.82	4.63	4.28	4.27
Short-Term Debt	-	4	4	-	-	-
Current Portion of Long-Term Debt	0.23	0.25	0.3	0.31	0.35	0.41
Current Portion of Leases	0.87	0.84	0.72	0.01	0.2	0.19
Current Income Taxes Payable	0.27	0.34	0.49	0.41	0.41	-
Current Unearned Revenue	-	0.01	0.01	0.01	0.01	0.01
Total Current Liabilities	10.67	11.84	13.05	7.83	6.69	5.81
Long-Term Debt	2.84	3.03	3.28	3.56	1.39	1.74
Long-Term Leases	2.36	2.8	3.44	-	0.84	0.04
Long-Term Unearned Revenue	-	-	0.01	0.02	0.03	0.05
Other Long-Term Liabilities	39.79	25.2	6.3	0.52	0.98	2.4
Total Liabilities	55.66	42.87	26.07	11.94	9.93	10.04
Common Stock	1.07	1.07	1.07	1.01	1.01	1.01
Additional Paid-In Capital	173.7	173.46	173.21	164.75	164.58	164.41
Retained Earnings	-112.89	-120.7	-116.39	-136.5	-140.06	-148.96
Treasury Stock	-0.31	-0.31	-0.31	-0.31	-0.31	-0.31
Total Common Equity	61.58	53.52	57.58	28.96	25.22	16.15
Shareholders' Equity	61.58	53.52	57.58	28.96	25.22	16.15
Total Liabilities & Equity	117.25	96.39	83.65	40.9	35.15	26.19
Total Debt	6.3	10.91	11.74	3.89	2.78	2.38
Net Cash (Debt)	20.32	0.4	-4.63	3.94	5.75	0.81
Net Cash Growth	-	-	-	-31.44%	606.63%	-
Net Cash Per Share	0.02	0.00	-0.00	0.00	0.01	0.00
Filing Date Shares Outstanding	1,074	1,068	1,068	1,014	1,011	1,009
Total Common Shares Outstanding	1,073	1,068	1,068	1,014	1,011	1,009
Working Capital	75.12	45.9	26.96	13.68	12.17	6.38
Book Value Per Share	0.06	0.05	0.05	0.03	0.02	0.02
Tangible Book Value	61.3	53.23	57.29	28.67	24.76	15.69
Tangible Book Value Per Share	0.06	0.05	0.05	0.03	0.02	0.02
Land	11.65	11.65	11.06	10.77	5.46	5.46
Machinery	16.03	15.71	15.02	14.24	13.85	13.35

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.